Post Profile






Testosterone-lowering drugs for prostate cancer may up the risk of dementia

Prostate cancer patients taking testosterone-lowering drugs may be twice as likely to develop dementia. The researchers found that males who underwent androgen-deprivation therapy (ADT) had an eight percent risk of dementia within five years of treatment, compared to only 3.5 … The post Testosterone-lowering drugs for prostate cancer may up the risk of dementia appeared first on Bel Marra Health - Breaking Health News and Health Information.
read more

share

Related Posts


Hormone Deprivation Therapy for Prostate Cancer May Raise Diabetes Risk

Health : Newswise Medical News

Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cance...

Prostate Cancer Treatment Linked to Dementia

Mental Health / Alzheimer's : Alzheimer's Reading Room

Men being treated with prostate cancer therapies that reduce their testosterone levels are at greater risk of developing dementia within five years. Reducing testosterone levels with androgen deprivation therapy (ADT) is a common tr...

Researchers Work to Determine Why Some Prostate Cancer Patients Experience More Hot Flashes during Therapy

Health : Newswise Medical News

Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt ...

Shorter Course of Androgen Deprivation Therapy for High-Risk Prostate Cancer Patients Yields Improved Quality of Life

Health : Newswise Medical News

High-risk prostate cancer patients who receive radiation therapy (RT) and an 18-month course of androgen deprivation therapy (ADT) recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-mo...

Prostate cancer hormone therapy tied to higher dementia risk

Health : Reuters: Health

(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of dementia than patients who receive different treatment for these malignancies, a U.S. study suggests.

Comments


Copyright © 2016 Regator, LLC